🇺🇸 FDA
Pipeline program

novel stent

320924197612177170

Phase 3 other active

Quick answer

novel stent for Esophageal Cancer is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Esophageal Cancer
Phase
Phase 3
Modality
other
Status
active

Clinical trials